BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26293709)

  • 1. Fractal dimension (df) as a new structural biomarker of clot microstructure in different stages of lung cancer.
    Davies NA; Harrison NK; Morris RH; Noble S; Lawrence MJ; D'Silva LA; Broome L; Brown MR; Hawkins KM; Williams PR; Davidson S; Evans PA
    Thromb Haemost; 2015 Nov; 114(6):1251-9. PubMed ID: 26293709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of exercise intensity on clot microstructure and mechanical properties in healthy individuals.
    Davies NA; Llwyd O; Brugniaux JV; Davies GR; Marley CJ; Hodson D; Lawrence MJ; D'Silva LA; Morris RH; Hawkins K; Williams PR; Bailey DM; Evans PA
    Thromb Res; 2016 Jul; 143():130-6. PubMed ID: 27240111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractal dimension: a novel clot microstructure biomarker use in ST elevation myocardial infarction patients.
    Lawrence MJ; Sabra A; Thomas P; Obaid DR; D'Silva LA; Morris RH; Hawkins K; Brown MR; Williams PR; Davidson SJ; Chase AJ; Smith D; Evans PA
    Atherosclerosis; 2015 Jun; 240(2):402-7. PubMed ID: 25890059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism.
    Lawrence MJ; Sabra A; Mills G; Pillai SG; Abdullah W; Hawkins K; Morris RH; Davidson SJ; D'Silva LA; Curtis DJ; Brown MR; Weisel JW; Williams PR; Evans PA
    Br J Haematol; 2015 Feb; 168(4):571-5. PubMed ID: 25302653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilution.
    Lawrence MJ; Kumar S; Hawkins K; Boden S; Rutt H; Mills G; Sabra A; Morris RH; Davidson SJ; Badiei N; Brown MR; Williams PR; Evans PA
    Thromb Res; 2014 Aug; 134(2):488-94. PubMed ID: 24965661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of venous thromboembolism among patients with primary lung cancer.
    Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
    J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of ROTEM to assess hypercoagulability in patients with lung cancer.
    Davies NA; Harrison NK; Sabra A; Lawrence MJ; Noble S; Davidson SJ; Evans VJ; Morris RH; Hawkins K; Williams PR; Evans PA
    Thromb Res; 2015 Jun; 135(6):1075-80. PubMed ID: 25895846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PO-25 - FATCAT: an observational cohort study investigating fractal dimension (df) as a biomarker of thrombogenicity in cancer associated thrombosis during chemotherapy for lung cancer.
    Davies NA; Noble S; Harrison NK; Morris RH; Evans PA
    Thromb Res; 2016 Apr; 140 Suppl 1():S185. PubMed ID: 27161712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased activity of procoagulant factors in patients with small cell lung cancer.
    Pedersen S; Kristensen AF; Falkmer U; Christiansen G; Kristensen SR
    PLoS One; 2021; 16(7):e0253613. PubMed ID: 34288927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unidirectional flow shear stresses on the formation, fractal microstructure and rigidity of incipient whole blood clots and fibrin gels.
    Badiei N; Sowedan AM; Curtis DJ; Brown MR; Lawrence MJ; Campbell AI; Sabra A; Evans PA; Weisel JW; Chernysh IN; Nagaswami C; Williams PR; Hawkins K
    Clin Hemorheol Microcirc; 2015; 60(4):451-64. PubMed ID: 25624413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study.
    Davies GR; Pillai S; Lawrence M; Mills GM; Aubrey R; D'Silva L; Battle C; Williams R; Brown R; Thomas D; Morris K; Evans PA
    Intensive Care Med; 2016 Dec; 42(12):1990-1998. PubMed ID: 27592210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease.
    Baker SR; Zabczyk M; Macrae FL; Duval C; Undas A; Ariëns RAS
    J Thromb Haemost; 2019 Apr; 17(4):618-626. PubMed ID: 30725502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic significance of coagulation assays in lung cancer.
    Tas F; Kilic L; Serilmez M; Keskin S; Sen F; Duranyildiz D
    Respir Med; 2013 Mar; 107(3):451-7. PubMed ID: 23200643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Temperature on Clot Microstructure and Strength in Healthy Volunteers.
    Lawrence MJ; Marsden N; Mothukuri R; Morris RH; Davies G; Hawkins K; Curtis DJ; Brown MR; Williams PR; Evans PA
    Anesth Analg; 2016 Jan; 122(1):21-6. PubMed ID: 26440418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the acute inflammatory response of burns and its treatment on clot characteristics and quality: A prospective case controlled study.
    Marsden NJ; Lawrence M; Davies N; Davies G; Morris K; Williams PR; Whitaker IS; Evans PA
    Burns; 2020 Aug; 46(5):1051-1059. PubMed ID: 31866177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of diabetic ketoacidosis (DKA) and its treatment on clot microstructure: Are they thrombogenic?
    Pillai S; Davies G; Lawrence M; Whitley J; Stephens J; Williams PR; Morris K; Evans PA
    Clin Hemorheol Microcirc; 2021; 77(2):183-194. PubMed ID: 32925001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.
    Undas A; Zawilska K; Ciesla-Dul M; Lehmann-Kopydłowska A; Skubiszak A; Ciepłuch K; Tracz W
    Blood; 2009 Nov; 114(19):4272-8. PubMed ID: 19690336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.